BRIM Biotechnology, Inc. (TPE:6885)
Taiwan
· Delayed Price · Currency is TWD 23.00
+0.05 (0.22%)
At close: Apr 29, 2026
BRIM Biotechnology Balance Sheet
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2019 |
| Cash & Equivalents | 798.43 | 502.76 | 948 | 837.99 | 399.75 | Upgrade
|
| Short-Term Investments | 360 | 1,346 | 747.63 | - | 23.84 | Upgrade
|
| Cash & Short-Term Investments | 1,158 | 1,849 | 1,696 | 837.99 | 423.59 | Upgrade
|
| Cash Growth | -37.34% | 9.03% | 102.34% | 97.83% | 149.98% | Upgrade
|
| Accounts Receivable | 0.63 | - | - | - | - | Upgrade
|
| Other Receivables | 41.82 | 23.36 | 6.24 | 0.45 | 0.37 | Upgrade
|
| Receivables | 42.46 | 23.36 | 6.24 | 0.45 | 0.37 | Upgrade
|
| Inventory | 0.67 | - | - | - | - | Upgrade
|
| Prepaid Expenses | 6.99 | 4.07 | 11.1 | 10.55 | 6.65 | Upgrade
|
| Other Current Assets | 0.14 | 0 | - | - | - | Upgrade
|
| Total Current Assets | 1,209 | 1,876 | 1,713 | 848.99 | 430.61 | Upgrade
|
| Property, Plant & Equipment | 14.51 | 11.79 | 6.37 | 7.99 | 3.62 | Upgrade
|
| Long-Term Investments | 23.55 | 38.27 | 57.3 | 82.33 | 60.35 | Upgrade
|
| Goodwill | 67.56 | - | - | - | - | Upgrade
|
| Other Intangible Assets | 512.06 | 483.39 | 1.34 | 0.09 | - | Upgrade
|
| Other Long-Term Assets | 1.37 | 1.02 | 0.7 | 0.59 | 0.86 | Upgrade
|
| Total Assets | 1,828 | 2,411 | 1,779 | 939.99 | 495.44 | Upgrade
|
| Accounts Payable | 0.85 | - | - | - | - | Upgrade
|
| Accrued Expenses | 47.36 | 15.52 | 36.04 | 16.99 | 12.34 | Upgrade
|
| Current Portion of Long-Term Debt | 2.97 | - | - | - | - | Upgrade
|
| Current Portion of Leases | 5.84 | 4.23 | 3.48 | 3.63 | 2.85 | Upgrade
|
| Current Unearned Revenue | 0.83 | - | - | - | - | Upgrade
|
| Other Current Liabilities | 9.09 | 331.08 | 2.52 | 1.87 | 2.05 | Upgrade
|
| Total Current Liabilities | 66.94 | 350.84 | 42.05 | 22.48 | 17.23 | Upgrade
|
| Long-Term Debt | 6.46 | - | - | - | - | Upgrade
|
| Long-Term Leases | 0.68 | 3.54 | 0.11 | 2.81 | 0.32 | Upgrade
|
| Total Liabilities | 74.08 | 354.38 | 42.16 | 25.3 | 17.55 | Upgrade
|
| Common Stock | 1,332 | 1,315 | 1,158 | 932.54 | 692.54 | Upgrade
|
| Additional Paid-In Capital | 1,364 | 1,636 | 1,725 | 589.72 | 454.31 | Upgrade
|
| Retained Earnings | -1,021 | -884.69 | -1,149 | -771.19 | -746.92 | Upgrade
|
| Comprehensive Income & Other | -20.38 | -9.85 | 2.95 | 163.63 | 77.96 | Upgrade
|
| Total Common Equity | 1,655 | 2,056 | 1,737 | 914.69 | 477.89 | Upgrade
|
| Minority Interest | 98.64 | - | - | - | - | Upgrade
|
| Shareholders' Equity | 1,754 | 2,056 | 1,737 | 914.69 | 477.89 | Upgrade
|
| Total Liabilities & Equity | 1,828 | 2,411 | 1,779 | 939.99 | 495.44 | Upgrade
|
| Total Debt | 15.96 | 7.78 | 3.59 | 6.44 | 3.16 | Upgrade
|
| Net Cash (Debt) | 1,142 | 1,841 | 1,692 | 831.55 | 420.42 | Upgrade
|
| Net Cash Growth | -37.94% | 8.80% | 103.48% | 97.79% | 157.57% | Upgrade
|
| Net Cash Per Share | 8.69 | 15.78 | 16.83 | 11.66 | 7.09 | Upgrade
|
| Filing Date Shares Outstanding | 133.21 | 131.5 | 115.75 | 93.25 | 69.25 | Upgrade
|
| Total Common Shares Outstanding | 133.21 | 131.5 | 115.75 | 93.25 | 69.25 | Upgrade
|
| Working Capital | 1,142 | 1,525 | 1,671 | 826.51 | 413.38 | Upgrade
|
| Book Value Per Share | 12.42 | 15.64 | 15.00 | 9.81 | 6.90 | Upgrade
|
| Tangible Book Value | 1,075 | 1,573 | 1,735 | 914.6 | 477.89 | Upgrade
|
| Tangible Book Value Per Share | 8.07 | 11.96 | 14.99 | 9.81 | 6.90 | Upgrade
|
| Machinery | 15.99 | 9.12 | 6.46 | 4.84 | 3.59 | Upgrade
|
| Leasehold Improvements | 3.67 | 3.67 | 3.44 | 3.19 | 3.07 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.